Article thumbnail

TLR1/2, TLR7, and TLR9 Signals Directly Activate Human Peripheral Blood Naive and Memory B Cell Subsets to Produce Cytokines, Chemokines, and Hematopoietic Growth Factors

By Sudhanshu Agrawal and Sudhir Gupta

Abstract

Recently, it has been reported that using multiple signals, murine and human B cells secrete several cytokines with pro-inflammatory and immunoregulatory properties. We present the first comprehensive analysis of 24 cytokines, chemokines, and hematopoietic growth factors production by purified human peripheral blood B cells (CD19+), and naive (CD19+CD27-) and memory (CD19+CD27+) B cells in response to direct and exclusive signaling provided by toll-like receptor (TLR) ligands Pam3CSK (TLR1/TLR2), Imiquimod (TLR7), and GpG-ODN2006 (TLR9). All three TLR ligands stimulated B cells (CD19+) to produce cytokines IL-1α, IL-1β, IL-6, TNF-α, IL-13, and IL-10, and chemokines MIP-1α, MIP-1β, MCP-1, IP-10, and IL-8. However, GM-CSF and G-CSF production was predominantly induced by TLR2 agonist. Most cytokines/chemokines/hematopoietic growth factors were predominantly or exclusively produced by memory B cells, and in general, TLR2 signal was more powerful than signal provided viaTLR7 and TLR9. No significant secretion of eotaxin, IFN-α, IFN-γ, IL-2, IL-3, IL-4, IL-5, IL-7, IL-15, IL-17, IL-12p40, IL-12p70, and TNF-β (lymphotoxin) was observed. These data demonstrate that human B cells can be directly activated viaTLR1/TLR2, TLR7, and TLR9 to induce secretion of cytokines, chemokines, and hematopoietic growth factors and suggest a role of B cells in immune response against microbial pathogenesis and immune homeostasis

Topics: Article
Publisher: Springer US
OAI identifier: oai:pubmedcentral.nih.gov:3064903
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. A case for regulatoryB cells.
  2. A distinct tolllike receptor repertoire in human tonsil B cells, directly activated by
  3. (2009). A novel regulatory B-cell population in sheep Peyer’s patches spontaneously secretes IL-10 and downregulates TLR9-induced IFNalpha responses. Mucosal Immunol.
  4. Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
  5. CD19+CD24hiCD38hi exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic lupus erythematosus patients.
  6. (2009). CXCL10 and autimmune diseases. Autoimmun Rev.
  7. (2008). Cytokine-producing B lymphocytes — key regulator of immunity. Curr Opin Immunol.
  8. Distinct effector cytokine profile of memory and naive human B cell subsets and implication in multiple sclerosis.
  9. (2005). Expression of toll-like receptors on B cells. Cell Immunol.
  10. (2011). G-CSF and GM-CSF as therapeutic targets in rheumatoid arthritis.
  11. (1999). Human non-germinal center B cell interleukin (IL)-12 production is primarily regulated by T cells signals CD40 ligand, interferon γ, and IL-10: role of B cells in the maintenance of T cell responses. J Exp Med.
  12. Identification of two subppulations of purified human Blood B cells, CD27–CD23+ and CD27highCD80+, that strongly express cell surface toll-like receptor 9 and secrete high levels of interleukin-6.
  13. IFN-α amplifies human naive B cell TLR-9-mediated activation and Ig production.
  14. IL12p70-dependent Th1 induction by human B cells requires combined activation with CD40 ligand and CpG DNA.
  15. (2008). Immune regulation by B cells and antibodies a view towards the clinic. Adv Immunol.
  16. Innate responses of B cells.
  17. (2002). Macrophage inflammatory protein 1. Cytokine Growth Factor Rev.
  18. Molecular basis for shared cytokine recognition revealed in the structure of an unusually high affinity complex between
  19. (2008). Not always the bad guys: B cells as regulators of autoimmune pathology. Nat Rev Immunol.
  20. (2005). Plasmacytoid dendritic cells control TLR7 sensitivity of naive B cells via type I IFN. J Immunol.
  21. (1997). Production of cytokines by human B cells in health and diseases. Immunol Today.
  22. Quantitative expression of toll-like receptor 1-10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides.
  23. Staphylococcus aureus protein A triggers T cellindependent B cell proliferation by sensitizing B cells for TLR2 ligands.
  24. (1995). The functional role of the ELR motif in CXC chemokine-mediated angiogenesis.
  25. The mucosal adjuvant macrophage-activating lipopeptide-2 directly stimulates B lymphocytes via the TLR2 without the need of accessory cells.
  26. (2007). TLR signaling. Sem Immunol.
  27. TLR stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function.
  28. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production.
  29. TLR-mediated stimulation of APC: distinct cytokine responses of B cells and dendritic cells.
  30. Toll-like receptor stimulation as a third signal required for activation of human naive B cells.
  31. (2005). Toll-like receptors: linking innate and adaptive immunity. Adv Exp Med Biol.
  32. (2002). Toll-like receptors. Ann Rev Immunol.
  33. Type I cytokine profile of human naive and memory B lymphocytes: a potential for memory cells to impact polarization.
  34. Type I interferons protect neonates from acute inflammation through interleukin-10 producing B cells.